NIH | National Cancer Institute | NCI Wiki  

Date

Attendees



Goals

  • Review, discuss and prioritize ICDC study submission proposals

Previous Action items

Discussion items

ItemWhoNotes
New UBC studyMusk, Philip (NIH/NCI) [C]
  • Coming from Debbie Knapp's group
  • Accession number would be 0009
  • Support for biobanking activity is available with the new multi-study matching feature
  • Voting resulted in 3 "yes" votes and the remainder will be acquired through email
Data Release DashboardKuffel, Gina (NIH/NCI) [C]
  • Tracks the state of studies across environments
  • Tracks the state of incoming studies 
Study Updates

Kuffel, Gina (NIH/NCI) [C], Musk, Philip (NIH/NCI) [C]

  • OSA01
  • OSA02
  • MGT01
Material Transfer Agreement (MTA)Kuffel, Gina (NIH/NCI) [C]
  • Intended to serve as a mechanism for reimbursement for the cost of preparing and submitting data

Minutes (Not Verbatim)

PM- OSA02 name will change. Tissues don't have pathology assignments. For the OSA01 study, for cell line, there is no indication of what type of cells are in the cell line. Instead of not applicable, we should call it a normal osteoclast cell line.

PM- Not always a financial constraint, but mostly a time constraint. Reimbursement for data submissions couldn't hurt. The type of people that want to submit data may not be further influenced by financial support.

RV- For some groups it may make a difference.

PM- We actually don't rely on data submitters to do any mapping. We only require them to provide a dictionary of the fields they are using. Researchers have done the work and published the paper, they have new studies ongoing, this is book keeping homework and it's a matter of researchers making the time.

MB- Maybe we need a way to address the broader NCI  so that canine data being generated is compliant with ICDC. Grants should include intentions to submit to ICDC. 

GT- How close are we to some type of a template?

PM- We are working towards having a comprehensive data dictionary inclusive of guidance.

PM- Adhoc questions for Matthew and Greg

GT- For publication of NCATS data, it has been provisionally accepted pending changes due Aug. 11th. 

PM- We now have a separate tab in the study page that can display publications on the production environment. When is the blood analysis data coming?
GT- Blood analysis and proteomic data is completed (at least the math) for the NCATS study, we will not release the data to ICDC until we have a draft, this will happen near the end of September.

PM- The new publications tab applies to Roel as well.

PM- We now support cross-study matching which will emphasize the relation of dogs that are in both 

GT- As we get more datasets entered into the system, we will have a gene by sample matrix, is it best to normalize all of the data together to generate an expression matrix? This will enable broad transcriptomic analysis.


Action items